SCHEMBL30954073

SCHEMBL30954073

CC(C)CCN1CCOc2c1cc(Cl)c(F)c2C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.35
KMO O15229 1/20 0.33
NOTUM Q6P988 1/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
RORC P51449 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
MAPT P10636 3/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MCL1 Q07820 3/20 0.31
BCL2 P10415 1/20 0.31
ALDH1A1 P00352 1/20 0.30
GRM2 Q14416 1/20 0.30
HTR4 Q13639 1/20 0.30
CYP1A2 P05177 1/20 0.30
ATM Q13315 1/20 0.30
PTGIR P43119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27433875 1.00 HSP90AA1 (0.35) HSP90AA1KMONOTUMHTR2AHTR2C
SCHEMBL27433869 0.89 ENPP2 (0.37) HSP90AA1NOTUMHTR2AHTR2CHTR2B
SCHEMBL30954098 0.89 ENPP2 (0.37) HSP90AA1NOTUMHTR2AHTR2CHTR2B
SCHEMBL30954145 0.87 AR (0.36) HSP90AA1NOTUMHTR2CMAPTLMNA
SCHEMBL27434163 0.87 AR (0.36) HSP90AA1NOTUMHTR2CMAPTLMNA
SCHEMBL27434015 0.84 CHRM1 (0.37) NOTUMMAPTLMNATSHRSMN1; SMN2
SCHEMBL30954157 0.84 CHRM1 (0.37) NOTUMMAPTLMNATSHRSMN1; SMN2
SCHEMBL27434272 0.84 TSHR (0.34) NOTUMMAPTLMNATSHRSMN1; SMN2
SCHEMBL30954047 0.84 TSHR (0.34) NOTUMMAPTLMNATSHRSMN1; SMN2
SCHEMBL30954063 0.82 HTR4 (0.38) NOTUMMAPTLMNATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed